Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Pelthos Therapeutics Announces First Quarter 2026 Financial Results
-
Chicago Atlantic BDC, Inc. Reports First Quarter 2026 Financial Results
-
Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting
-
Iridium to Acquire Aireon, Advancing its Strategy to Lead the Future of Aviation Safety
-
illumin and Cint make brand measurement immediate and actionable in programmatic advertising
-
Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress
-
Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update
-
Solo Brands, Inc. Announces Fiscal 2026 First Quarter Results
-
American Shared Hospital Services Reports First Quarter 2026 Financial Results
-
Americold Delivering Centralized Cold Chain Logistics Solutions to PLUS in the Netherlands
-
Deep Isolation Nuclear, Inc. Reports Operational and Financial Results for the First Quarter of 2026
-
EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data
-
Bitdeer Reports Unaudited Financial Results for the First Quarter of 2026
-
OTC Markets Group Welcomes Summit Royalties Ltd to OTCQX
-
Precision BioSciences Presents New Preclinical Data Supporting the Advancement of PBGENE-DMD into Clinic at the American Society of Gene & Cell Therapy 2026 Annual Meeting
-
AST SpaceMobile Commends Proposed Direct-to-Device Joint Venture by U.S. Mobile Network Operators
-
Fiserv Launches agentOS: The Operating System for Agentic AI in Banking
-
OTC Markets Group Welcomes PRINCE SILVER CORP to OTCQX
-
VTEM Airborne Survey is Underway on VR’s Empire Copper-Nickel-PGM Project in Ontario
-
GH Research Reports First Quarter 2026 Financial Results and Provides Business Update
-
CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder
-
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update
-
XORTX Announces US$5 Million Public Offering
-
Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
-
REGENXBIO Announces Positive Topline Results from Pivotal Phase III AFFINITY DUCHENNE® Study of RGX-202
-
Talisker Announces 2026 Mineral Resource Statement for the Bralorne Gold Project
-
Mezzion Secures Strategic Financing to Support Advancement of Global Phase 3 FUEL-2 Trial in Fontan Patients
-
Boralex reports higher operating income and the addition of new growth projects in the first quarter of 2026
-
Anduril Industries Named Flagship Sponsor of BlueTIDE 2026
-
bidadoo Reports Robust Q1 2026 Growth as Online Equipment Remarketing Demand Surges
-
BCE to participate in the J.P. Morgan 2026 Global Technology, Media and Communications Conference in Boston
-
Innoviz Reports First Quarter 2026 Results
-
Synack’s Analysis of 11,000+ Vulnerabilities Reveals Top Weaknesses Attackers Are Weaponizing Today
-
Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab
-
CryptoSlots Celebrates 8th Birthday with VR Slots, New Game Launches and Month-Long Promotions
-
Fermi Inc. Outlines Fermi 2.0 Strategic Evolution and Reports First Quarter 2026 Financial Results
-
Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
-
URBAN ONE, INC. REPORTS FIRST QUARTER 2026 RESULTS
-
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
-
NG ENERGY ANNOUNCES FILING OF Q1 2026 FINANCIAL RESULTS
-
Destination XL Group, Inc. to Announce First Quarter 2026 Financial Results on Thursday, May 28, 2026
-
Concorde International Group Secures Multi-Year Contracts Worth Over US$10 Million for Integrated Security Solutions in Singapore
-
Signant Health Acquires Ametris to Create an End-to-End eCOA and Digital Outcome Measures Platform
-
POET Technologies and Lumilens Advance Wafer-Level Photonic Integration for Next-Generation AI Optical Networks
-
GEMMABio Unveils Duchenne Muscular Dystrophy (DMD) Program and Presents Preclinical Data for Next‑Generation Gene Therapies for DMD and Spinal Muscular Atrophy Type 1 (SMA1) at the ASGCT 2026 Annual
-
Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
-
WhiteFiber, Inc. Reports First Quarter 2026 Results
-
Bitcoin.com Partners with Dinari to Bring Tokenized U.S. Equities to a Global Audience
-
Akamai Technologies Announces Intent to Acquire LayerX, Advancing Its Workforce Security Strategy with AI Usage Control
-
Main Street Middletown, MD Inc. RECEIVES DESIGNATION AS A 2026 MAIN STREET AMERICA ACCREDITED PROGRAM

